LungLife AI Inc LLAI-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 09/24/21 BST
198.50UNCH (UNCH)
52 week range
188.00 - 213.89
Loading...
  • Open198.50
  • Day High0.00
  • Day Low0.00
  • Prev Close198.50
  • 52 Week High213.89
  • 52 Week High Date09/23/21
  • 52 Week Low188.00
  • 52 Week Low Date07/08/21

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume1,840.64
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open198.50
  • Day High0.00
  • Day Low0.00
  • Prev Close198.50
  • 52 Week High213.89
  • 52 Week High Date09/23/21
  • 52 Week Low188.00
  • 52 Week Low Date07/08/21
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume1,840.64
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On LungLife AI Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
LungLife AI Inc. is a United States-based cancer diagnostics company. The Company is focused on cancer treatment and management through the artificial intelligence (AI) enabled molecular analysis of cancer biomarkers in blood. It is focused on lung cancer from simple blood draw diagnostic solutions. Its technologies include LiquidBiopsy. LiquidBiopsy uses a blood draw, rather than a tissue biopsy, to discover the genomic mutations present or absent within an individual that...
Simon Raab Ph.D.
Chairman
Sara Barrington
Chief Executive Officer
Address
2545 W. Hillcrest Drive, Suite 140
Thousand Oaks, CA
91320
United States